Mental Health & Substance UseCruce, G., Ojehagen, A., & Nordstrom, M. (2008). Experiences of alcohol and other drugs in individuals with severe mental illness and concomitant substance use disorders. Mental Health and Substance Use: Dual diagnosis, 1(3), 228-241....
Objective To characterize the risk and degree of QT prolongation in patients with COVID-19 in association with their use of hydroxychloroquine with or without concomitant azithromycin. Design, Setting, and Participants This was a cohort study performed at an academic tertiary care center in Boston, ...
Because the choice of antipseudomonal antibiotics may vary by hospital, the groups were chosen owing to the similarity in their spectrum of activity and clinical indications for the drugs they used. In addition, children receiving non-antipseudomonal, as opposed to antipseudomonal, β-lactam ...
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your perso...
Co-administration of colchicine to patients along with certain other drugs can have the effect of increasing colchicine levels. Such drug-drug interactions with colchicine have been reported to result in serious morbid complications and, in some cases, death....
had received immunoglobulins or blood products in the previous 3 months, had a history of allergy or reactions to any component of the trial vaccines, had a bleeding disorder or continuous use of anticoagulants, suspected or known drug or alcohol dependence, or a progressive neurological disorder....
I will disclose the use of those drugs and (57) disclosed a high molecular weight bile acid reabsorption inhibitors with [summary] complications bile acid adsorption, containing manufacturing method of the inhibitor, these compounds further. (Meaning is illustrated in the specification B R ~R d, ...
Results: A total of 5493 patients with breast cancer who concomitantly used cardiovascular therapy were identified; 1811 who discontinued adjuvant hormone therapy were individually matched to 1 patient each who continued therapy by year of breast cancer diagnosis, age at ...
Use of the starting dose of 100 mg/m2 in patients younger than 60 years and 80 mg/m2 among those 60 years or older was allowed, provided that this practice was followed throughout the study. FEC consisted of intravenous fluorouracil (600 mg/m2), epirubicin hydrochloride (75 mg/m2), and...